- Home
- About INHN.
- Towards education.
- Central Office (Cordoba Unit).
- Carlos Morra: Central Office
- Administrative Unit by Leon S. Morra
- Carlos Morra: Chronological list of essential publications
- Carlos Morra: Guide for Authors
- Thomas A. Ban: Recommended additions
- ADMINISTRATIVE UNIT.
- EDUCATION.
- Thomas A. Ban Neuropsychopharmacology in Historical Perspective - Education in the Field in the Post-Neuropsychopharmacology Era.
- Bulletin 1: Educational Series 2. Jacques-Joseph Moreau de Tours.
- Bulletin 2 : Educational Series 2.Prologue
- Bulletin 3 : Educational Series 2. Vignette 1 Overview of the series: An Oral History of Neuropsychopharmacology
- Bulletin 4 : Educational Series 2. Chapter 1: John Dalton’s atomic theory and drugs in psychiatry in the 19th century
- Educational Series 2. Bulletin 5. Vignette 2: Sedatives in the second part of the 19th century
- Educational Series 2. Bulletin 6, Chapter 2: From William Cullen’s “neuroses” to Johann Christian Reil’s “psychiaterie”
- Educational Series 2. Bulletin 7, Vignette 3: Classifications of insanity in the late 18th and early 19th century
- Educational Series 2. Bulletin 8, Chapter 3: Substances with an effect on consciousness
- Educational Series 2. Bulletin 9 Vignette 4 :The isolation of morphine
- Bulletin 10 : Reflexes of the brain
- Bulletin 11 : Sechenov’s re-evaluation of mental faculties and the brain
- Bulletin 12 : Bayle’s discovery and the re-evaluation of the concept of dementia
- Bulletin 13 : Louis Sokoloff Autobiography – Regional mapping and imaging of the nervous system
- Bulletin 14 : Joseph J. Schildkraut: Autobiography – The catecholamine hypothesis before and thereafter
- Bulletin 15 : Alfred Pletscher Autobiography – On the Eve of the Birth of the Neurotransmitter Era in Biological Psychiatry
- Bulletin 16 : Leo E. Hollister’s Interview of Julius Axelrod – The Uptake of Neurotransmitters and Psychoactive Drugs
- Bulletin 17 : Thomas A. Ban’s Interview of Irwin J. Kopin – Metabolic disposition of catecholamines
- Bulletin 18 : Thomas A. Ban’s Interview of Philip B. Bradley – Recording Electrical Activity from Cerebral Cortex and Subcortical Structures in Conscious Cats
- Bulletin 19 : From Conditioning and Psychiatry to Psychopharmacology*
- Bulletin 20 : Conditioning and Psychiatry
- Bulletin 21 : Psychopharmacology
- Bulletin 22 : Physiological patterns: A diagnostic test procedure based on the conditional reflex method
- Bulletin 23 : Clinical pharmacology of psychotropic drugs
- Bulletin 24 : Methodology and pitfalls in clinical testing of psychopharmacological drugs
- Bulletin 25 : Toxicity and Adverse Reaction Studies with Neuroleptics and Antidepressants
- Bulletin 26 : The effect of phenothiazines on the electrocardiogram
- Bulletin 27 : Skin pigmentation, a rare side effect of chlorpromazine
- Bulletin 28 : Ernst Feuchtersleben’s separation of psychosis from neurosis
- Bulletin 29 : Wilhelm Griesinger and Unitary Psychosis (Einheitpsychose)
- Bulletin 30 : Towards Neuropsychopharmacology in 1957
- Bulletin 31 : Fifty years CINP
- Bulletin 32 : Fifty years ACNP
- Bulletin 33 : Starting Up (Volume One): 1. The Interviews
- Bulletin 34 : Starting Up (Volume One): 2. Psychiatry
- Bulletin 35 : Starting Up (Volume One): 3. Drugs
- Bulletin 36 : Starting Up (Volume One): 4. Pharmacology
- Bulletin 37 : Starting Up (Volume One): 5. Interviewees
- Bulletin 38 : Neurophysiology (Volume Two): 1. Early Development
- Bulletin 39 : Neurophysiology (Volume Two): 2. Interviewees Contributions
- Bulletin 40 : Neuropharmacology (Volume Three): 1. Neurotransmitters
- Bulletin 41 : Neuropharmacology (Volume Three): 2. Psychotropic drugs
- Bulletin 42 : Neuropharmacology (Volume Three): 3a. Contributions of Interviewees
- Bulletin 43 : Neuropharmacology (Volume Three): 3b. Contributions of Interviewees
- Bulletin 44 : Psychopharmacology (Volume Four): 1. Clinical methodology
- Bulletin 45 : Psychopharmacology (Volume Four): 2a. Contributions of Interviewees
- Bulletin 46 : Psychopharmacology (Volume Four): 2b. Contributions of Interviewees
- Bulletin 47 : Psychopharmacology (Volume Four): 2c. Contributions of Interviewees
- Bulletin 48 : Neuropsychopharmacology (Volume Five): 1.Model Psychosis
- Bulletin 49 : Neuropsychopharmacology (Volume Five): 2. Psychotoxic metabolites
- Bulletin 50 : Neuropsychopharmacology (Volume Five): 3. Psychopharmacology of Schizophrenia; Psychopharmacology of Depression; Endocrine Measures
- Bulletin 51 : Neuropsychopharmacology (Volume Five): 4a. Contributions of Interviewees
- Bulletin 52 : Neuropsychopharmacology (Volume Five): 4b. Contributions of Interviewees
- Bulletin 53 : Neuropsychopharmacology (Volume Five): 4c. Contributions of Interviewees
- Bulletin 54 : Addiction (Volume Six): 1. Addiction Psychiatry
- Bulletin 55 : Addiction (Volume Six): 2. Substances of abuse
- Bulletin 56 : Addiction (Volume Six): 3. Conditioning and addiction
- Bulletin 57 : Addiction (Volume Six): 4a. Contributions of interviewees
- Bulletin 58 : Addiction (Volume Six): 4b. Contributions of interviewees.
- Bulletin 59 : Special Areas (Volume Seven): 1. Child Psychiatry
- Bulletin 60 : Special Areas (Volume Seven): 2. Geriatric Psychiatry
- Bulletin 61 : Special Areas (Volume Seven): 3. Psychiatric diagnosis
- Bulletin 62 : Special Areas (Volume Seven): 4. Pharmacokinetics
- Bulletin 63 : Special Areas (Volume Seven): 5a. Contributions of Interviewees.
- Bulletin 64 : Special Areas (Volume Seven): 5b. Contributions of Interviewees
- Bulletin 65 : Special Areas (Volume Seven): 5c. Contributions of Interviewees
- Bulletin 66 : Diverse Topics (Volume Eight): 1. Regulation, Ethics, Marketing and Education, Conflict of Interest
- Bulletin 67 : Diverse Topics (Volume Eight): 2a. Interviewees Contributions
- Bulletin 68 : Diverse Topics (Volume Eight): 2b. Interviewees Contributions
- Bulletin 69 : Update (Volume Nine): 1. Pharmacogenetics and Genetics and Neuropsychopharmacology
- Bulletin 70 : Update (Volume Nine): 2. Psychopathology and Nosology
- Bulletin 71 : Update (Volume Nine): 3a. Interviewee’s Contributions
- Bulletin 72 : Update (Volume 9) 3b. Interviewees contributions
- Bulletin 73 : Volume 10. Postscript
- Bulletin 74 : An Overview of Developments in Psychopharmacology and Neuropsychopharmacology
- Bulletin 75 : The confounding of education with marketing
- Bulletin 76 : Towards a genetic era in neuropsychopharmacology
- Bulletin 77 : The CODE System
- Bulletin 78 : Nosologic Homotyping
- Collated Bulletin 1: RDoC in Historical Perspective.
- Collated Bulletin 2 : Neuropsychopharmacology and the Forgotten Language of Psychiatry
- Collated Bulletin 3 : In Historical Perspective: Peralta, Cuesta and their associate’s findings on the highest familiality of Leonhard’s Classification in Polynosologic Study
- Collated Bulletin 4: Thomas A. Ban: The Birth of a Medical Discipline: Psychiatry
- Collated Bulletin 5: Thomas A. Ban: Conflict of Interest in Neuropsychopharmacology. Marketing vs. Education.
- Collated Bulletin 6: Edward Shorter: The QT interval and the Mellaril story
- Collated Bulletin 7 : Thomas A. Ban: The Wernicke – Kleist – Leonhard Tradition with Special Reference to Mania, Melancholia and Manic – Depressive Psychosis.
- Collated Bulletin 8 : Thomas A. Ban: The Birth of Drug Industry and Drugs with An Effect On Behavior
- Collated Bulletin 9 : Thomas A. Ban: From Melancholia to Depression
- Collated Bulletin 10 : Thomas A. Ban: The Year 1845
- Collated Bulletin 11 : Joseph Knoll: The discovery of monoamine oxidase (MAO) enzymes.
- Collated Bulletin 12 : Samuel Gershon: Events and Memories
- Collated Bulletin 13 : Paul Devenyi: Addictions are not treatable diseases and Pharmacotherapy of addiction not a success story.
- Collated Bulletin 14 : Janos Radó: The use of modern antidiuretic agents in the treatment of permanent lithium-induced nephrogenic diabetes insipidus
- Collated Bulletin 15 : Per Bech: Clinical Psychometrics
- Collated Bulletin 16 : Martin M. Katz: Onset of clinical effects of antidepressants
- Collated Bulletin 17 : Martin M. Katz: Depression and Drugs, a monograph and Multivantaged vs Conventional Assessment, an essay
- Collated Bulletin 18 : Per Bech: Measurement-based care in mental disorders (New York: Springer; 2016) Foreword and Review
- Collated Bulletin 19 : Donald F. Klein and John Davis: Diagnosis and Drug Treatment of Mental Disorders and Thomas A. Ban: Psychopharmacology in 1969
- Collated Bulletin 20 : Thomas A. Ban: Schizophrenia in the Early 1970s
- Collated Bulletin 21 : Thomas A. Ban, Marcelo Cetkovich-Bakmas, Ernst Franzek and Hector Warnes: Carl Wernicke’s “elementary symptoms” and “sejunction hypothesis”
- Collated Bulletin 22 : Martin M. Katz: Clinical Trials of Antidepressants: How Changing the Model Can Uncover New, More Effective Molecules
- Collated Bulletin 23 : Joseph Knoll: From the Theory of Active Reflexes to a Neurochemical Concept of Innate and Acquired Drive
- Collated Bulletin 24 : Ildiko Miklya: The History of Selegiline (-) Deprenyl the First Selective Inhibitor of B-Type Monoamine Oxidase and the First Synthetic Catecholaminergic Enhancer Substance
- Collated Bulletin 25 : Joseph Knoll: The Discovery of the Enhancer Regulation in the Mammalian Brain and the Development of the Synthetic Enhancer Substances
- Collated Bulletin 26 : Profiles of clinicians and researchers who were instrumental for the birth and/or contributed to the development of neuropsychopharmacology: Julius Axelrod, Frank Ayd, Frank Berger, Hans Berger and Hermann Blaschko
- Collated Bulletin 27 : Profiles of clinicians and researchers who were instrumental for the birth and/or contributed to the development of neuropsychopharmacology. Charles Bradley, Philip B. Bradley, Bernard B. Brodie, John Cade and John Delay
- Collated Bulletin 28 : Profiles of clinicians and researchers who were instrumental for the birth and/or contributed to the development of neuropsychopharmacology. Edmundo Fischer, W. Horsley Gantt, Turan M. Itil, Hitoshi Itoh and Paul Kielholz
- Collated Bulletin 29 : Profiles of clinicians and researchers who were instrumental for the birth and/or contributed to the development of neuropsychopharmacology. Nathan S. Kline, Roland Kuhn, Heinz E. Lehmann, Laszlo Meduna and Dionisio Nieto Gomez
- Collated Bulletin 30 : Profiles of clinicians and researchers who were instrumental for the birth and/or contributed to the development of neuropsychopharmacology. Alfred Pletscher, Juri Saarma, Sydney Spector, Leo Sternbach, Edward Trautner and Joseph Wo
- Collated Bulletin 31 : Thomas A. Ban: Lithium. 1. Discovery of its therapeutic effect in psychiatry. Johan Schioldann, William T. Hammond and Carl Lange
- Collated Bulletin 32 : Thomas A. Ban: Lithium in Psychiatry in Historical Perspective. 2. Introduction into treatment in psychiatry. Samuel Gershon: Profiles of John Cade and Edward Trautner
- Collated Bulletin 33 : Thomas A. Ban: Lithium in Psychiatry in Historical Perspective. 3. Early Years. Samuel Gershon: First-Hand Accounts
- Collated Bulletin 34 : Thomas A. Ban: Lithium in Psychiatry in Historical Perspective
- Collated Bulletin 35 : Thomas A. Ban: Lithium. 4. Controversy. Barry Blackwell vs Paul Grof and Jules Angst
- Collated Bulletin 36 : Thomas A. Ban: Lithium in Psychiatry in Historical Perspective 5. Turning point. Paul Grof and Johan Schioldann
- Collated Bulletin 37 : Thomas A. Ban: Lithium in Psychiatry in Historical Perspective 6. Action. Janusz Rybakowski
- Collated Bulletin 38 : Thomas A. Ban: 7. Diagnosis
- Collated Bulletin 39 : Thomas A. Ban: Lithium in Psychiatry in Historical Perspective Dedication and Preface
- Collated Bulletin 40 : Thomas A. Ban: Lithium in Psychiatry in Historical Perspective.
- Collated Bulletin 41 : Peter R. Martin. Volume 1. Recollections of the History of Neuropsychopharmacology Through Interviews Conducted by Thomas A. Ban
- Collated Bulletin 42 : Peter R. Martin. Volume 2. Recollections of the History of Neuropsychopharmacology Through Interviews Conducted by Leo E. Hollister
- Collated Bulletin 43 : Peter R. Martin. Volume 2. Recollections of the History of Neuropsychopharmacology Through Interviews Conducted by William E. Bunney, Jr.
- Lehmann Collection 1 : Charles E. Cahn’s interview of Heinz E. Lehmann.
- Lehmann Collection 2 : William E. Bunney’s interview of Heinz E. Lehmann
- Lehmann Collection 3 : Heinz Edgar Lehmann by Barry Blackwell
- Lehmann Collection 4 : Heinz Lehmann and Douglas Hospital by Charles C. Cahn
- Lehmann Collection 5 : Heinz Edgar Lehmann’s research profile by Antonio E. Nardi.
- Lehmann Collection 6 : Heinz E. Lehmann by Edward Shorter.
- Lehmann Collection 7 : Per Bech’s comment on Heinz E. Lehmann*
- Lehmann Collection 8 : Paul Grof’s comment on Heinz E. Lehmann. A few personal recollections
- Lehmann Collection 9 : Irwin J. Kopin’s comment on Heinz E. Lehmann.
- Lehmann Collection 10 : Mary and Philip Seeman's comment
- Lehmann Collection 11 : A Tribute to Heinz Edgar Lehmann by Hector Warnes.
- Lehmann Collection 12 : Heinz Edgar Lehmann: Publication
- Lehmann Collection 13 : Thomas A. Ban: My Personal Notes on Heinz Lehmann
- Lehmann Collection 14 : Thomas A. Ban: Heinz E. Lehmann and Psychopharmacology
- Lehmann Collection 15 : Thomas A. Ban: Towards a clinical methodology for neuropsychological research
- Lehmann Collection 16 : Heinz Edgar Lehmann
- Lehmann Collection 17 : Heinz E. Lehmann: What is wrong with getting old?
- Lehmann Collection 18 : Heinz E. Lehmann: Dreaming about Mental Health
- Lehmann Collection 19: Heinz E. Lehmann: Alcoholism, aggression and androgen function. Discussion of paper by Jack Mendelson
- Lehmann Collection 20: Heinz E. Lehmann: Perspectives in Psychosurgery
- Lehmann Collection 21 : Heinz E. Lehmann: Discussion of the paper by Prof. P. Pichot: The Treatment of Depression
- Lehmann Collection 22 : Heinz E. Lehmann: Harlem Valley Revisited
- Lehmann Collection 23 : Heinz E. Lehmann: Chlorpromazine: The Story of Phenothiazine Derivatives, Their Clinical Indications, the Incidence and Management of Untoward Effects and a Proposed Rational for Its Action
- Lehmann Collection 24 : Heinz E. Lehmann: The Anatomy of Research Funding
- Lehmann Collection 25 : Program of Academic morning in honor of Dr. Heinz Lehmann
- Lehmann Collection 26 : Heinz E. Lehmann: Types and Characteristics of Objective Measures of Psychopathology
- Classification of Functional Psychoses 1 : Preface and Recommended Reading
- Classification of Functional Psychoses 2 : Introduction
- Classification of Functional Psychoses 3 : ICD-9 and DSM-III
- Classification of Functional Psychoses 4: Classification of Mental Disorders and Psychopharmacology – Diagnostic Criteria for Research
- Classification of Functional Psychoses 5: The KDK Budapest
- Classification of Functional Psychoses 6: One- and Two-Dimensional Diagnoses
- Classification of Functional Psychoses 7: Delusional Development and Delusional Psychoses
- Classification of Functional Psychoses 8: Bayle’s Unitary Concept of Psychosis and Endogenous Psychoses
- Classification of Functional Psychoses 9: Affective Psychosis
- Classification of Functional Psychoses 10: Empirical and Pragmatic Classifications of Depression
- Classification of Functional Psychoses 11: Schizophrenic Psychoses
- Classification of Functional Psychoses 12: Cycloid Psychoses
- Classification of Functional Psychoses 13: Conclusions
- Classification of Functional Psychoses 14: References
- Delcir da Costa’s comment on collating document
- Dementia Differential Diagnosis 1991 : Contents
- Dementia Differential Diagnosis 1991 : Conceptual Development
- Dementia Differential Diagnosis 1991 : Dementing Illnesses
- Dementia Differential Diagnosis 1991 : Modified Concept
- Dementia Differential Diagnosis 1991 : Diagnosing of Dementing Illness
- Dementia Differential Diagnosis 1991 : References
- Methodology pitfalls of clinical testing of psychopharmaceutical
- Mental health (Psychiatry) and pharmaceuticals in a historical perspective
- Nosology in the teaching of psychiatry. Introduction
- Towards a clinical methodology for neuropsychopharmacological research
- Selective Drugs Versus Heterogeneous Diagnoses. Towards a New Methodology in Psychopharmacologic Research
- Per Bech: Members of the International Committee for the Prevention and Treatment of Depression in the mid-1980s
- Per Bech and Wolfgang Rutz: The Story of the International Committee for the Prevention and Treatment of Depression
- Peter R. Martin: Historical Dictionary of Addiction.
- Amara McLaughlin-Harris: The Legal History of Psychoactive Drugs.
- Carlos Morra: An Educational Model in Psychiatry.
- Carlos Morra and Ernst Franzek: Psychopathological Symptoms.
- Carlos Morra and Mateo Kreiker: Psychopathology.
- Thomas A. Ban Neuropsychopharmacology in Historical Perspective - Education in the Field in the Post-Neuropsychopharmacology Era.
- INHN Publisher.
- Programs.
- Courses.
- Interviews.
- Copyright Policy
- How to cite INHN
- Website Table of Contents
- Last Uploads
Thomas A. Ban: Neuropsychopharmacology in Historical Perspective. Dementia Differential Diagnosis
Conceptual Development
CLICK HERE TO OPEN THE DOCUMENTS
August 12, 2021